148 related articles for article (PubMed ID: 38575942)
1. Development and validation of a model and nomogram for breast cancer diagnosis based on quantitative analysis of serum disease-specific haptoglobin N-glycosylation.
Li L; Xu Y; Lai Z; Li D; Sun Q; Li Z; Zhou Y
J Transl Med; 2024 Apr; 22(1):331. PubMed ID: 38575942
[TBL] [Abstract][Full Text] [Related]
2. Disease-Specific haptoglobin N-Glycosylation in inflammatory disorders between cancers and benign diseases of 3 types of female internal genital organs.
Lai Z; Wang Z; Yuan Z; Zhang J; Zhou J; Li D; Zhang D; Li N; Peng P; Zhou J; Li Z
Clin Chim Acta; 2023 Jul; 547():117420. PubMed ID: 37285951
[TBL] [Abstract][Full Text] [Related]
3. Disease-specific haptoglobin-β chain N-glycosylation as biomarker to differentiate non-small cell lung cancer from benign lung diseases.
Chen T; He C; Zhang M; Li X; Liu X; Liu Y; Zhang D; Li Z
J Cancer; 2019; 10(23):5628-5637. PubMed ID: 31737099
[No Abstract] [Full Text] [Related]
4. Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects.
Fujimura T; Shinohara Y; Tissot B; Pang PC; Kurogochi M; Saito S; Arai Y; Sadilek M; Murayama K; Dell A; Nishimura S; Hakomori SI
Int J Cancer; 2008 Jan; 122(1):39-49. PubMed ID: 17803183
[TBL] [Abstract][Full Text] [Related]
5. Designation of fingerprint glycopeptides for targeted glycoproteomic analysis of serum haptoglobin: insights into gastric cancer biomarker discovery.
Lee J; Hua S; Lee SH; Oh MJ; Yun J; Kim JY; Kim JH; Kim JH; An HJ
Anal Bioanal Chem; 2018 Feb; 410(6):1617-1629. PubMed ID: 29285644
[TBL] [Abstract][Full Text] [Related]
6. Glycopeptide Biomarkers in Serum Haptoglobin for Hepatocellular Carcinoma Detection in Patients with Nonalcoholic Steatohepatitis.
Zhu J; Huang J; Zhang J; Chen Z; Lin Y; Grigorean G; Li L; Liu S; Singal AG; Parikh ND; Lubman DM
J Proteome Res; 2020 Aug; 19(8):3452-3466. PubMed ID: 32412768
[TBL] [Abstract][Full Text] [Related]
7. An integrated nomogram combining deep learning, Prostate Imaging-Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study.
Hiremath A; Shiradkar R; Fu P; Mahran A; Rastinehad AR; Tewari A; Tirumani SH; Purysko A; Ponsky L; Madabhushi A
Lancet Digit Health; 2021 Jul; 3(7):e445-e454. PubMed ID: 34167765
[TBL] [Abstract][Full Text] [Related]
8. Construction and validation of nomogram for the cancer-specific mortality for HER2-positive breast cancer patients.
Wu N
Medicine (Baltimore); 2024 Mar; 103(11):e37330. PubMed ID: 38489717
[TBL] [Abstract][Full Text] [Related]
9. [Construction of a nomogram prediction model for pathological complete response (pCR) of ipsilateral supraclavicular lymph node after neoadjuvant chemotherapy for breast cancer with first diagnosis of ipsilateral supraclavicular lymph node metastasis].
Lyu MH; Jiao DC; Wu JZ; Tian PQ; Ma YZ; Liu ZZ; Chen XC
Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):160-166. PubMed ID: 35184460
[No Abstract] [Full Text] [Related]
10. [Differential diagnosis model of benign and malignant breast BI-RADS category 4 nodules based on serum SP70 and conventional laboratory indicators].
Ding HM; Xu J; Wang F; Zhang Q; Pan H; Mu Y; Gu CR; Miao SX; Li XN; Ju HY; Wang L; Pan SY
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Dec; 56(12):1774-1783. PubMed ID: 36536565
[No Abstract] [Full Text] [Related]
11. A nomogram for predicting the HER2 status in female patients with breast cancer in China: a nationwide, multicenter, 10-year epidemiological study.
Zhang H; Xie P; Li Z; Huang R; Feng W; Kong Y; Xu F; Zhao L; Song Q; Li J; Zhang B; Fan J; Qiao Y; Xie X; Zheng S; He J; Wang K
Diagn Pathol; 2019 May; 14(1):35. PubMed ID: 31054583
[TBL] [Abstract][Full Text] [Related]
12. A Mammography-Based Radiomic Nomogram for Predicting Malignancy in Breast Suspicious Microcalcifications.
Chen Y; Jiang H; Li J; Zhang J; Wu P; Dai Z
Acad Radiol; 2024 Feb; 31(2):492-502. PubMed ID: 37940427
[TBL] [Abstract][Full Text] [Related]
13. A Nomogram for Enhancing the Diagnostic Effectiveness of Solid Breast BI-RADS 3-5 Masses to Determine Malignancy Based on Imaging Aspects of Conventional Ultrasonography and Contrast-Enhanced Ultrasound.
Yan M; Peng C; He D; Xu D; Yang C
Clin Breast Cancer; 2023 Oct; 23(7):693-703. PubMed ID: 37394416
[TBL] [Abstract][Full Text] [Related]
14. A Nomogram and Risk Classification System Predicting the Prognosis of Patients with De Novo Metastatic Breast Cancer Undergoing Immediate Breast Reconstruction: A Surveillance, Epidemiology, and End Results Population-Based Study.
Zhao J; Bian S; Di X; Xiao C
Curr Oncol; 2023 Dec; 31(1):115-131. PubMed ID: 38248093
[TBL] [Abstract][Full Text] [Related]
15. A nomogram for distinguishing benign and malignant parotid gland tumors using clinical data and preoperative blood markers: development and validation.
Zhao F; Huang X; He J; Li J; Li Q; Wei F; Chen H; Su J
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11719-11733. PubMed ID: 37402966
[TBL] [Abstract][Full Text] [Related]
16. Use of CA15‑3 for screening breast cancer: An antibody‑lectin sandwich assay for detecting glycosylation of CA15‑3 in sera.
Choi JW; Moon BI; Lee JW; Kim HJ; Jin Y; Kim HJ
Oncol Rep; 2018 Jul; 40(1):145-154. PubMed ID: 29749490
[TBL] [Abstract][Full Text] [Related]
17. Application Values of 2D and 3D Radiomics Models Based on CT Plain Scan in Differentiating Benign from Malignant Ovarian Tumors.
Li S; Liu J; Xiong Y; Han Y; Pang P; Luo P; Fan B
Biomed Res Int; 2022; 2022():5952296. PubMed ID: 35224097
[TBL] [Abstract][Full Text] [Related]
18. Predicting the risk of axillary lymph node metastasis in early breast cancer patients based on ultrasonographic-clinicopathologic features and the use of nomograms: a prospective single-center observational study.
Fong W; Tan L; Tan C; Wang H; Liu F; Tian H; Shen S; Gu R; Hu Y; Jiang X; Mei J; Liang J; Hu T; Chen K; Yu F
Eur Radiol; 2022 Dec; 32(12):8200-8212. PubMed ID: 36169686
[TBL] [Abstract][Full Text] [Related]
19. Construction and validation of a machine learning-based nomogram: A tool to predict the risk of getting severe coronavirus disease 2019 (COVID-19).
Yao Z; Zheng X; Zheng Z; Wu K; Zheng J
Immun Inflamm Dis; 2021 Jun; 9(2):595-607. PubMed ID: 33713584
[TBL] [Abstract][Full Text] [Related]
20. Predicting Breast Cancer in Breast Imaging Reporting and Data System (BI-RADS) Ultrasound Category 4 or 5 Lesions: A Nomogram Combining Radiomics and BI-RADS.
Luo WQ; Huang QX; Huang XW; Hu HT; Zeng FQ; Wang W
Sci Rep; 2019 Aug; 9(1):11921. PubMed ID: 31417138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
